NELOVA Trademark

Trademark Overview

On Monday, June 18, 2012, a trademark application was filed for NELOVA with the United States Patent and Trademark Office. The USPTO has given the NELOVA trademark a serial number of 85654262. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 9, 2016. This trademark is owned by WARNER CHILCOTT COMPANY, LLC. The NELOVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of menopausal symptoms, hormone replacement therapy; oral contraceptives; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anesthesia, oncology, infection, inflammation, urology, gynecology; pharmaceutical preparations and substances for the treatment and prevention of diabetes; pharmaceutical preparations for the treatment of menopause and its symptoms; pharmaceutical preparation containing estrogen used to treat osteoporosis and menopause and its symptoms
nelova

General Information

Serial Number85654262
Word MarkNELOVA
Filing DateMonday, June 18, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 9, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of menopausal symptoms, hormone replacement therapy; oral contraceptives; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anesthesia, oncology, infection, inflammation, urology, gynecology; pharmaceutical preparations and substances for the treatment and prevention of diabetes; pharmaceutical preparations for the treatment of menopause and its symptoms; pharmaceutical preparation containing estrogen used to treat osteoporosis and menopause and its symptoms

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 26, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type77 - NOT AVAILABLE
AddressCOOLOCK, DUBLIN 17
IE
Party NameWARNER CHILCOTT COMPANY, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFAJARDO 00738
PR
Party NameWARNER CHILCOTT COMPANY, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFAJARDO 00738
PR

Trademark Events

Event DateEvent Description
Wednesday, February 19, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, June 21, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, May 9, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 9, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 13, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 12, 2015EXTENSION 5 GRANTED
Thursday, October 1, 2015EXTENSION 5 FILED
Thursday, October 1, 2015TEAS EXTENSION RECEIVED
Thursday, April 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2015EXTENSION 4 GRANTED
Wednesday, April 1, 2015EXTENSION 4 FILED
Wednesday, April 1, 2015TEAS EXTENSION RECEIVED
Wednesday, October 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2014EXTENSION 3 GRANTED
Wednesday, October 1, 2014EXTENSION 3 FILED
Wednesday, October 1, 2014TEAS EXTENSION RECEIVED
Tuesday, July 1, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 1, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 26, 2014EXTENSION 2 GRANTED
Friday, February 21, 2014EXTENSION 2 FILED
Friday, March 21, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 21, 2014TEAS EXTENSION RECEIVED
Saturday, September 21, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 19, 2013EXTENSION 1 GRANTED
Thursday, September 19, 2013EXTENSION 1 FILED
Thursday, September 19, 2013TEAS EXTENSION RECEIVED
Tuesday, April 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 5, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 5, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 16, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 29, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, December 29, 2012ASSIGNED TO LIE
Wednesday, December 12, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 12, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, December 12, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 12, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, December 12, 2012EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 9, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 9, 2012NON-FINAL ACTION E-MAILED
Tuesday, October 9, 2012NON-FINAL ACTION WRITTEN
Tuesday, October 2, 2012ASSIGNED TO EXAMINER
Tuesday, June 26, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 21, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

nelova pharmaceutical system preparations treatment substances symptoms menopause nervous prevention inflammation